Sirna Therapeutics Inc | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Sirna Therapeutics Inc

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
562	31	0	RNAI

Emcee: advinfo	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
162	I'm impressed with the volume today. Let's hope that those who are buy	Baker	-	9/23/1998
161	Baker, thanks for the clarification and for the explanation of the fast track p	Thomas	-	9/23/1998
160	No, the info on the completion of Phase I/IIa trials was back in January. Here	Baker	-	9/23/1998
159	Baker, am I mistaken or is this the first mention that the HIV clinical trials	Thomas	-	9/23/1998
158	For those of us who are in for the long term, this is good news. IMO we need t	Baker	-	9/22/1998
157	Also mentioned in Dick davis digest, price target still 110. I'll take 50	Scott Ozer	-	9/22/1998
156	also made DJ Newswire Ribozyme Pharm Submits INDA To Begin Testing Cancer Drug	bob zagorin	-	9/22/1998
155	Ribozyme Pharmaceuticals Submits IND for Anti-Angiogenesis Agent to Treat Cance	bob zagorin	-	9/22/1998
154	Hi, yes, still out here and holding on to my Ribozyme. If I recall, the end of	Baker	-	9/11/1998
153	I'm here! trial results may be out soon.	Scott Ozer	-	9/11/1998
152	anybody alive out there? rzym showing some strength today but i haven't see	bob zagorin	-	9/11/1998
151	does this mean i can exchange my rzym shares for an equal amount of yhoo? can i	bob zagorin	-	8/31/1998
150	Does anyone know why RZYM is down almost 35% this morning? Not that there is m	DGMontana	-	8/31/1998
149	Ribozyme Pharmaceuticals, Inc. Reports Second Quarter Financial Results BOULDE	bob zagorin	-	8/12/1998
148	Bob: Better hope they don't need any money for the next few years. Seriou	billkirn	-	8/4/1998
147	9m shares outstanding at 3.25. rzym's market is now under $30m. pretty damn	bob zagorin	-	8/4/1998
146	RZYM has already completed their Phase I/IIa clinical trials on their HIV/AIDS	Baker	-	7/30/1998
145	David and all: Immusol, a RZYM competitor announced its HIV ribozyme patent to	Thomas	-	7/30/1998
144	B: In view of the much higher price the company once commanded, it was previou	David Bogdanoff	-	7/28/1998
143	thanks david. when rzym fell below $5, it put some pressure on my margin accoun	bob zagorin	-	7/28/1998
142	To All: See more good news at biz.yahoo.com David	David Bogdanoff	-	7/28/1998
141	Thanks for the response. Does McCamant have a thread? CTSL with Michael Murph	DGMontana	-	7/9/1998
140	Rzym should trade at 2.25 where I'll be loading up, of course they could sa	Scott Ozer	-	7/8/1998
139	Jerry: DON'T KNOW WHAT STOCKS MTSL FOLLOWS BUT, a slew of the ones Mike Mu	Don S.Boller	-	7/8/1998
138	David, According to the Medical Technology Stock Letter, one or two funds have	G-MAN	-	7/8/1998

Go to reply# or date (mm/dd/yy):